Statistics for Tempest Therapeutics (id:5987 TPST)
Valuation metrics
Market cap
39.62M
Enterprise value
13.50M
Trailing P/E (ttm)
-0.47
Forward P/E
-0.63
PEG ratio
-0.63
Price/Sales (ttm)
Price/Book (mrq)
0.71
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.43
Overview
Shares outstanding
43.64M
Float
21.69M
Shares short
2.64M
% Held by insiders
0.00%
% Held by institutions
0.23%
Average volume (10 days)
2.60M
Average volume (90 days)
Price summary
52-Week low
0.80
52-Week high
6.00
52-Week change
-316.12%
Beta
-2.78
50-Day moving average
1.18
200-Day moving average
2.46
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
December 10th, 2018
Ex-dividend date
Last split factor
2:1
Last split date
June 28th, 2021
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-54.28%
Return on equity
-289.26%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-31,246,000.00
Net income to common (ttm)
-31,748,000.00
Diluted EPS (ttm)
-1.53
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
31.12M
Total cash per share (mrq)
1.24
Total debt (mrq)
20.26M
Total Debt/Equity (mrq)
119.58
Current ratio (mrq)
216.70%
Book value per share (mrq)
1.21
Cash flow
Cash flow statement
-25,358,000.00
Levered free cash flow (LFCF)
-15,198,000.00